InsidersTradesSigma
海泰新光 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Follow the 海泰新光 stock price and the full insider trade history of the company, a listed equity based in China. Shares are listed on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 海泰新光 has published 43 public disclosures. Market capitalisation: €14.4bn. The latest transaction was disclosed on 28 May 2026 (Sale). Among the most active insiders: 毛荣壮. The full history is free.
43
Insider Decl.
0
Thresholds
·
3 ops.
Buy Volume
€12m
40 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 11,026 of 25,567 companies
55.5
score / 100
Value31
Quality80
FCF yld1.3%
Earn yld1.7%
EV/EBITDA45.3x
ROE12%
Gross mgn66%
Net mgn28%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 28 May 2026
Declarations43 total
1,160,000 sharesA股XSHGSSE:173000009849836640
518,000 sharesA股XSHGSSE:173000009835521820
200,000 sharesA股XSHGSSE:173000009831685100
200,000 sharesA股XSHGSSE:173000009827587600
25 of 43 declarations
About 海泰新光
Haitai Xinguang is a publicly traded company on the Shanghai Stock Exchange, specializing in technology. It focuses on the development and production of innovative solutions for various markets.